Reduced incidence and delayed onset of diabetes in perforin-deficient nonobese diabetic mice

Journal of Experimental Medicine

Volumn 186, Issue 7, 1997, Pages 989-997

  Kägi, David ^a   Odermatt, Bernhard ^b   Seiler, Peter ^b   Zinkernagel, Rolf M ^b   Mak, Tak W ^a   Hengartner, Hans ^b  

^a PRINCESS MARGARET HOSPITAL   (Canada)

^b UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; PERFORIN;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; AUTOIMMUNITY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DIABETES MELLITUS; DIABETOGENESIS; GLUCOSE BLOOD LEVEL; IMMUNOHISTOCHEMISTRY; NONHUMAN; PANCREAS ISLET CELL; PRIORITY JOURNAL;

ANIMALS; AUTOIMMUNE DISEASES; BLOOD GLUCOSE; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CROSSES, GENETIC; CYCLOPHOSPHAMIDE; DIABETES MELLITUS, TYPE 1; DISEASE MODELS, ANIMAL; FEMALE; IMMUNOSUPPRESSIVE AGENTS; ISLETS OF LANGERHANS; MALE; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED NOD; PANCREAS; PORE FORMING CYTOTOXIC PROTEINS; T-LYMPHOCYTES, CYTOTOXIC;

EID: 1842289172     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.186.7.989     Document Type: Article

References (43)

1. Makino, S., K. Kunimoto, Y. Muraoka, Y. Mizushima, K. Katagiri, and Y. Tochino. 1980. Breeding of a non-obese diabetic strain of mice. Exp. Anim. (Tokyo). 29:1-13.
2. + T cells. J. Exp. Med. 166:823-832.
3. + T cell subsets are required for the transfer of diabetes in nonobese diabetic mice. J. Immunol. 140:52-58.
4. Bradley, B.J., K. Haskins, F.G. La Rosa, and K.J. Lafferty. 1992. CD8 T cells are not required for islet destruction induced by a CD4-positive islet-specific T cell clone. Diabetes. 41:1603-1608.
5. Katz, J.D., and C. Benoist. 1995. T helper cell subsets in insulin-dependent diabetes. Science (Wash. DC). 268:1185-1188.
6. Jarpe, A.J., M.R. Hickman, J.T. Anderson, W.E. Winter, and A.B. Peck. 1991. Flow cytometric enumeration of mononuclear cell populations infiltrating the islets of Langerhans in prediabetic NOD mice: development of a model of autoimmune insulitis for type 1 diabetes. Reg. Immunol. 3: 305-317.
7. Bottazzo, G.F., B.M. Dean, J.M. McNally, E.H. MacKay, P.G.F. Swift, and D.R. Gamble. 1985. In situ characterization of autoimmune phenomena and expression of HLA molecules in the pancreas in diabetic insulitis. N. Engl. J. Med. 313:353-360.
8. Katz, J., C. Benoist, and D. Mathis. 1993. Major histocompatibility complex class I molecules are required for the development of insulitis in non-obese diabetic mice. Eur. J. Immunol. 23:3358-3360.
9. Wicker, L.S., E.H. Leiter, J.A. Todd, R.J. Renjilian, E. Peterson, P.A. Fischer, P.L. Podolin, M. Zijlstra, R. Jaenisch, and L.B. Peterson. 1994. β2-microglobulin-deficient mice do not develop insulitis or diabetes. Diabetes. 43:500-504.
10. Sumida, T., M. Furukawa, A. Sakamoto, T. Namekawa, T. Maeda, M. Zijlstra, I. Iwamoto, T. Koike, S. Yoshida, H. Tomioka, and M. Taniguchi. 1994. Prevention of insulitis and diabetes in β2-microglobulin-deficient non-obese diabetic mice. Int. Immunol. 6:1445-1449.
11. null mice are diabetes and insulitis resistant. Diabetes. 43:505-509.
12. + T cells in the initiation of insulin-dependent diabetes mellitus. Eur. J. Immunol. 26:1762-1769.
13. Wong, F.S., I. Visintin, L. Wen, R.A. Flavell, and C.A. Janeway. 1996. CD8 T cell clones from young nonobese diabetic (NOD) islets can transfer rapid onset of diabetes in NOD mice in the absence of CD4 cells. J. Exp. Med. 183:67-76.
14. Kägi, D., B. Ledermann, K. Bürki, P. Seiler, B. Odermatt, K.J. Olsen, E. Podack, R.M. Zinkernagel, and H. Hengartner. 1994. Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice. Nature (Lond.). 369:31-37.
15. Kägi, D., F. Vignaux, B. Ledermann, K. Bürki, V. Depraetere, S. Nagata, H. Hengartner, and P. Golstein. 1994. Fas and perform pathways as major mechanisms of T cell-mediated cytotoxicity. Science (Wash. DC). 265:528-530.
16. Kojima, H., N. Shinohara, S. Hanaoka, Y. Someya-Shirota, Y. Takagaki, H. Ohno, T. Saito, T. Katayama, H. Yagita, K. Okumura, et al. 1994. Two distinct pathways of specific killing revealed by perform mutant cytotoxic T lymphocytes. Immunity. 1:357-364.
17. Lowin, B., F. Beermann, A. Schmidt, and J. Tschopp. 1994. A null mutation in the perform gene impairs cytolytic T lymphocyte-and natural killer cell-mediated cytotoxicity. Proc. Natl. Acad. Sci. USA. 91:11571-11575.
18. Walsh, C.M., M. Matloubian, C.-C. Liu, R. Ueda, C.G. Kurahara, J.L. Christensen, M.T.F. Huang, J.D.-E. Young, R. Ahmed, and W.R. Clark. 1994. Immune function in mice lacking the perform gene. Proc. Natl. Acad. Sci. USA. 91:10854-10858.
19. Ohashi, P.S., S. Oehen, K. Bürki, H.P. Pircher, C.T. Ohashi, B. Odermatt, B. Malissen, R. Zinkernagel, and H. Hengartner. 1991. Ablation of "tolerance" and induction of diabetes by virus infection in viral antigen transgenic mice. Cell. 65:305-317.
20. Kägi, D., B. Odermatt, P.S. Ohashi, R.M. Zinkemagel, and H. Hengartner. 1996. Development of insulitis without diabetes in transgenic mice lacking perforin-dependent cytotoxicity. J. Exp. Med. 183:2143-2152.
21. Todd, J.A., T.J. Aitman, R.J. Cornall, S. Ghosh, J.R. Hall, C.M. Hearne, A.M. Knight, J.M. Love, M.A. McAleer, and J.B. Prins. 1991. Genetic analysis of autoimmune type 1 diabetes mellitus in mice. Nature (Lond.). 351:542-547.
22. Cobbold, S.P., A. Jayasuriya, A. Nash, T.D. Prospero, and H. Waldmann. 1984. Therapy with monoclonal antibodies by elimination of T cell subsets in vivo. Nature (Lond.). 312:548-551.
23. Weibel, E.R. 1973. Stereological techniques for electron microscopy. In Principles and Techniques of Electron Microscopy. Biological Applications. Vol.3. M.A. Hayat, editor. Van Nostrand Reinhold Company, New York. 237-296.
24. Harada, M., and S. Makino. 1984. Promotion of spontaneous diabetes in non-obese diabetic-prone mice by cyclophosphamide. Diabetologia. 37:604-606.
25. Zhang, Z.L., H.M. Georgiou, and T.E. Mandel. 1993. The effect of cyclophosphamide treatment on lymphocyte subsets in the nonobese diabetic mouse: a comparison of various lymphoid organs. Autoimmunity. 15:1-10.
26. + lymphocytes. Diabetes. 37:1108-1112.
27. Charlton, B., A. Bacelj, and T.E. Mandel. 1988. Administration of silica particles or anti-Lyt2 antibody prevents β-cell destruction in NOD mice given cyclophosphamide. Diabetes. 37:930-935.
28. + lymphocytes in autoimmune disease. Studies on spontaneous and adoptively transferred diabetes in nonobese diabetic mice. J. Immunol. 143:3994-3999.
29. Trapani, J.A., B.Y. Kwon, C.A. Kozak, C. Chintamaneni, J.D.-E. Young, and B. Dupont. 1989. Genomic organization of the mouse pore-forming protein (perform) gene and localization to chromosome 10: similarities to and differences from C9. J. Exp. Med. 171:545-557.
30. Wicker, L.S., J.A. Todd, and L.B. Peterson. 1995. Genetic control of autoimmune diabetes in the NOD mouse. Annu. Rep. Immunol. 13:179-200.
31. Müller, C., D. Kägi, T. Aebischer, B. Odermatt, W. Held, E.R. Podack, R.M. Zinkernagel, and H. Hengartner. 1989. Detection of perform and granzyme A mRNAs in infiltrating cells during LCMV infection of mice. Eur. J. Immunol. 19: 1253-1259.
32. Shehadeh, N.N., and K.J. Lafferty. 1993. The role of T-cells in the development of autoimmune diabetes. Diabetes Rev. 1: 141-151.
33. Leithäuser, F., J. Dhein, G. Mechtersheimer, K. Koretz, S. Brüderlein, C. Henne, A. Schmidt, K.-M. Debatin, P.H. Krammer, and P. Möller. 1993. Constitutive and induced expression of APO-1, a new member of the nerve growth factor/tumor necrosis factor receptor superfamily, in normal and neoplastic cells. Lab. Invest. 69:415-429.
34. Stassi, G., M. Todaro, P. Richiusa, M. Giordano, A. Mattina, M.S. Sbriglia, A. Lo Monte, G. Buscemi, A. Galluzo, and C. Giordano. 1995. Expression of apoptosis-inducing CD95 (Fas/Apo-1) on human β-cells sorted by flow cytometry and cultured in vitro. Transplant. Proc. 27:3271-3275.
35. Chervonsky, A.V., Y. Wang, S. Wong, I. Visintin, R. Flavell, C.A. Janeway, and L.A. Matis. 1997. The role of Fas in autoimmune diabetes. Cell. 89:17-24.
36. Giordano, C., G. Stassi, R. De Maria, M. Todaro, P. Richiusa, G. Papoff, G. Ruberti, M. Bagnasco, R. Testi, and A. Galluzzo. 1997. Potential involvement of Fas and its ligand in the pathogenesis of Hashimoto's thyroiditis. Science (Wash. DC). 275:960-963.
37. Bendtzen, K., T. Mandrup-Poulsen, J. Nerup, J.H. Nielsen, C.A. Dinarello, and M. Svenson. 1986. Cytotoxicity of human pI 7 interleukin-1 for pancreatic islets of Langerhans. Science (Wash. DC). 232:1545-1547.
38. Corbett, J.A., and M.L. McDaniel. 1992. Perspectives in diabetes: does nitric oxide mediate autoimmune destruction of β-cells? Possible therapeutic interventions in IDDM. Diabetes. 41:897-903.
39. Campbell, I.L., A. Iscaro, and L.C. Harrison. 1988. IFN-γ and tumor necrosis factor-α cytototoxicity to murine islets of Langerhans. J. Immunol. 141:2325-2329.
40. Mandrup-Poulsen, T., K. Bendtzen, C.A. Dinarello, and J. Nerup. 1987. Human necrosis factor potentiates human interleukin-1 mediated rat pancreatic β-cell cytotoxicity. J. Immunol. 139:4077-4082.
41. Yang, X.-D., R. Tisch, S.M. Singer, Z.A. Cao, R.S. Liblau, R.D. Schreiber, and H.O. McDevitt. 1994. Effect of tumor necrosis factor α on insulin-dependent diabetes mellitus in NOD mice. I. The early development of autoimmunity and the diabetogenic process. J. Exp. Med. 180:995-1004.
42. von Herrath, M.G., and M.B.A. Oldstone. 1996. Interferon γ is essential for destruction of β cells and development of insulin-dependent diabetes mellitus. J. Exp. Med. 185:531-539.
43. Hultgren, B., X. Huang, N. Dybal, and T.A. Stewart. 1996. Genetic absence of γ-interferon delays but does not prevent diabetes in NOD mice. Diabetes. 45:812-817.